NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1063734484|ref|NP_001332513|]
View 

ENHANCED DISEASE RESISTANCE protein (DUF1336) [Arabidopsis thaliana]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PLN00188 super family cl33420
enhanced disease resistance protein (EDR2); Provisional
60-778 8.93e-105

enhanced disease resistance protein (EDR2); Provisional


The actual alignment was detected with superfamily member PLN00188:

Pssm-ID: 215094 [Multi-domain]  Cd Length: 719  Bit Score: 337.55  E-value: 8.93e-105
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484  60 YFGWVYHLGVNKIGHEYCNLRFLFIRGKYVEMYKRDPHENpdIKPIRRGVIGPTMVIEELGRrKVNHGD-VYVIRFYNRL 138
Cdd:PLN00188    6 YEGWMVRYGRRKIGRSYIHMRYFVLESRLLAYYKKKPQDN--QVPIKTLLIDGNCRVEDRGL-KTHHGHmVYVLSVYNKK 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 139 DESRKGEIACATAGEALKWVEAFEEA-KQQAEYALSRG---GSTRTKLSMEANI----------------DLEGHRPRVR 198
Cdd:PLN00188   83 EKYHRITMAAFNIQEALIWKEKIESViDQHQDSQVPNGnkyASFEYKSGMDNGRtasssdhesqfsaqedEEDTHRDLLR 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 199 RYAyglkklirIGQG-PESLLrqSSTLVNDVrgdGFYEGGDNGDAIEAHEWKCVRTINGVRIFEDVANF-----KAGRGV 272
Cdd:PLN00188  163 RTT--------IGNGpPDSVL--DWTKEFDS---ELSNQNSNNQAFSRKHWRLLQCQNGLRIFEELLEVdylprSCSRAM 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 273 lvKAVAVVEASADTVFEVLLNIDKhQRYEWDAVTGDSEKIDSYEGHYDVIYciydpkylSRIFCRWQSK----RDFVFSR 348
Cdd:PLN00188  230 --KAVGVVEATCEEIFELVMSMDG-TRFEWDCSFQYGSLVEEVDGHTAILY--------HRLQLDWFPMfvwpRDLCYVR 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 349 QWVRGQDGTYTILQFPAVHKKRPAKSGYRRTEITPSTWEIKSLKKRSdaETPSCLVTHMLEIHSKRWCKWKRTSYSkfek 428
Cdd:PLN00188  299 YWRRNDDGSYVVLFRSREHENCGPQPGFVRAHLESGGFNISPLKPRN--GRPRTQVQHLMQIDLKGWGVGYIPSFQ---- 372
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 429 tipYALLLQ----VAGLKEYIGAN---------PAFKYETSATVVQSKfqdvpngeyvdeEMEEQFYDATDSSSGEEDEE 495
Cdd:PLN00188  373 ---QHCLLQmlnsVAGLREWFSQTdergappriPVMVNMASASVSSKK------------NQKPQESSPSLDQTNAASRN 437
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 496 ESDDDDENQDNKEIKVKLKNVSWAIASLSLKRpkapgaSNVLDASVDPvsIDPSQFQGSLRKGNGDKDSNCWNSPSGMGF 575
Cdd:PLN00188  438 SVMMDEDSDDDEEFQIPESEQEPETTKNETKD------TAMEEEPQDK--IDLSCFSGNLRRDDRDKARDCWRISDGNNF 509
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 576 MIRGKTYLKDNAKVMGGQPLLTLISVDWFKVDSAVDNIALHPKCLIQSEPGKKLpFILVINLQVPAKPNYCLVLYYAADR 655
Cdd:PLN00188  510 KVRSKNFCYDKSKIPAGKHLMDLVAVDWFKDTKRMDHVARRKGCAAQVAAEKGL-FSFVVNLQVPGSTHYSMVFYFVTKE 588
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 656 PVnKTSSLGKFVDGSDSYRDARFKLIPSIVQGYWMVKRAVGTKACLLGKAVTCKYLRQDNFLEIDVDIGSSAVARSVIGL 735
Cdd:PLN00188  589 LV-PGSLLQRFVDGDDEFRNSRLKLIPSVPKGSWIVRQSVGSTPCLLGKAVDCNYIRGPKYLEIDVDIGSSTVANGVLGL 667
                         730       740       750       760
                  ....*....|....*....|....*....|....*....|...
gi 1063734484 736 VLGYVTSLIVDLAILIEGKEESDLPEYILGTVRLNRIELDSAV 778
Cdd:PLN00188  668 VIGVITTLVVDMAFLVQANTYEELPERLIGAVRVSHVELSSAI 710
 
Name Accession Description Interval E-value
PLN00188 PLN00188
enhanced disease resistance protein (EDR2); Provisional
60-778 8.93e-105

enhanced disease resistance protein (EDR2); Provisional


Pssm-ID: 215094 [Multi-domain]  Cd Length: 719  Bit Score: 337.55  E-value: 8.93e-105
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484  60 YFGWVYHLGVNKIGHEYCNLRFLFIRGKYVEMYKRDPHENpdIKPIRRGVIGPTMVIEELGRrKVNHGD-VYVIRFYNRL 138
Cdd:PLN00188    6 YEGWMVRYGRRKIGRSYIHMRYFVLESRLLAYYKKKPQDN--QVPIKTLLIDGNCRVEDRGL-KTHHGHmVYVLSVYNKK 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 139 DESRKGEIACATAGEALKWVEAFEEA-KQQAEYALSRG---GSTRTKLSMEANI----------------DLEGHRPRVR 198
Cdd:PLN00188   83 EKYHRITMAAFNIQEALIWKEKIESViDQHQDSQVPNGnkyASFEYKSGMDNGRtasssdhesqfsaqedEEDTHRDLLR 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 199 RYAyglkklirIGQG-PESLLrqSSTLVNDVrgdGFYEGGDNGDAIEAHEWKCVRTINGVRIFEDVANF-----KAGRGV 272
Cdd:PLN00188  163 RTT--------IGNGpPDSVL--DWTKEFDS---ELSNQNSNNQAFSRKHWRLLQCQNGLRIFEELLEVdylprSCSRAM 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 273 lvKAVAVVEASADTVFEVLLNIDKhQRYEWDAVTGDSEKIDSYEGHYDVIYciydpkylSRIFCRWQSK----RDFVFSR 348
Cdd:PLN00188  230 --KAVGVVEATCEEIFELVMSMDG-TRFEWDCSFQYGSLVEEVDGHTAILY--------HRLQLDWFPMfvwpRDLCYVR 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 349 QWVRGQDGTYTILQFPAVHKKRPAKSGYRRTEITPSTWEIKSLKKRSdaETPSCLVTHMLEIHSKRWCKWKRTSYSkfek 428
Cdd:PLN00188  299 YWRRNDDGSYVVLFRSREHENCGPQPGFVRAHLESGGFNISPLKPRN--GRPRTQVQHLMQIDLKGWGVGYIPSFQ---- 372
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 429 tipYALLLQ----VAGLKEYIGAN---------PAFKYETSATVVQSKfqdvpngeyvdeEMEEQFYDATDSSSGEEDEE 495
Cdd:PLN00188  373 ---QHCLLQmlnsVAGLREWFSQTdergappriPVMVNMASASVSSKK------------NQKPQESSPSLDQTNAASRN 437
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 496 ESDDDDENQDNKEIKVKLKNVSWAIASLSLKRpkapgaSNVLDASVDPvsIDPSQFQGSLRKGNGDKDSNCWNSPSGMGF 575
Cdd:PLN00188  438 SVMMDEDSDDDEEFQIPESEQEPETTKNETKD------TAMEEEPQDK--IDLSCFSGNLRRDDRDKARDCWRISDGNNF 509
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 576 MIRGKTYLKDNAKVMGGQPLLTLISVDWFKVDSAVDNIALHPKCLIQSEPGKKLpFILVINLQVPAKPNYCLVLYYAADR 655
Cdd:PLN00188  510 KVRSKNFCYDKSKIPAGKHLMDLVAVDWFKDTKRMDHVARRKGCAAQVAAEKGL-FSFVVNLQVPGSTHYSMVFYFVTKE 588
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 656 PVnKTSSLGKFVDGSDSYRDARFKLIPSIVQGYWMVKRAVGTKACLLGKAVTCKYLRQDNFLEIDVDIGSSAVARSVIGL 735
Cdd:PLN00188  589 LV-PGSLLQRFVDGDDEFRNSRLKLIPSVPKGSWIVRQSVGSTPCLLGKAVDCNYIRGPKYLEIDVDIGSSTVANGVLGL 667
                         730       740       750       760
                  ....*....|....*....|....*....|....*....|...
gi 1063734484 736 VLGYVTSLIVDLAILIEGKEESDLPEYILGTVRLNRIELDSAV 778
Cdd:PLN00188  668 VIGVITTLVVDMAFLVQANTYEELPERLIGAVRVSHVELSSAI 710
EDR2_C pfam07059
Protein ENHANCED DISEASE RESISTANCE 2, C-terminal; This family represents the C-terminus ...
567-771 1.45e-95

Protein ENHANCED DISEASE RESISTANCE 2, C-terminal; This family represents the C-terminus (approximately 250 residues) of protein ENHANCED DISEASE RESISTANCE 2 (EDR2) from plants. EDR2 is a negative regulator of the salicylic acid (SA)-mediated resistance to pathogens, including the biotrophic powdery mildew pathogens Golovinomyces cichoracearum and Blumeria graminis, and the downy mildew pathogen Hyaloperonospora parasitica, probably by limiting the initiation of cell death and the establishment of the hypersensitive response (HR).


Pssm-ID: 462076  Cd Length: 211  Bit Score: 296.05  E-value: 1.45e-95
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 567 WNSPSGMGFMIRGKTYLKDNAKVMGGQPLLTLISVDWFKVDSAVDNIALHPKCLIQSEP-----GKKLPFILVINLQVPA 641
Cdd:pfam07059   1 WSEPDGSTFKVRGPNYLKDKKKVPAGPPLYELVGVDLFKSPKKIDHIASRPELPVALKPsekgaSGKVPFVFVVNLQVPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 642 kPNYCLVLYYAADRPV--NKTSSLGKFVDGSDSYRDARFKLIPSIVQGYWMVKRAVGTKACLLGKAVTCKYLRQDNFLEI 719
Cdd:pfam07059  81 -PGYSLVLYFATEEPLpdDEGSLLDRFVDGDDAFRNERFKLIPRIVNGPWIVKQAVGGKPVLIGKALTCKYHRGHNYFEI 159
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|..
gi 1063734484 720 DVDIGSSAVARSVIGLVLGYVTSLIVDLAILIEGKEESDLPEYILGTVRLNR 771
Cdd:pfam07059 160 DVDIHSSSYARKGLSLVLGYLKSLVVDLGFTIEGQTEEELPERLLGAVRLNK 211
START cd00177
Lipid-binding START domain of mammalian STARD1-STARD15 and related proteins; This family ...
238-441 1.01e-35

Lipid-binding START domain of mammalian STARD1-STARD15 and related proteins; This family includes the steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domains of mammalian STARD1-STARD15, and related domains, such as the START domain of the Arabidopsis homeobox protein GLABRA 2. The mammalian STARDs are grouped into 8 subfamilies. This family belongs to the SRPBCC (START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC) domain superfamily of proteins that bind hydrophobic ligands. SRPBCC domains have a deep hydrophobic ligand-binding pocket. For some members of this family, specific lipids that bind in this pocket are known; these include cholesterol (STARD1/STARD3/ STARD4/STARD5), 25-hydroxycholesterol (STARD5), phosphatidylcholine (STARD2/ STARD7/STARD10), phosphatidylethanolamine (STARD10) and ceramides (STARD11). The START domain is found either alone or in association with other domains. Mammalian STARDs participate in the control of various cellular processes including lipid trafficking between intracellular compartments, lipid metabolism, and modulation of signaling events. Mutation or altered expression of STARDs is linked to diseases such as cancer, genetic disorders, and autoimmune disease. The Arabidopsis homeobox protein GLABRA 2 suppresses root hair formation in hairless epidermal root cells.


Pssm-ID: 176851 [Multi-domain]  Cd Length: 193  Bit Score: 133.62  E-value: 1.01e-35
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 238 DNGDAIEAHE-WKCVRTINGVRIFEDVanFKAGRGVLVKAVAVVEASADTVFEVLLNIDKhqRYEWDAVTGDSEKIDSYE 316
Cdd:cd00177     6 ELLELLEEPEgWKLVKEKDGVKIYTKP--YEDSGLKLLKAEGVIPASPEQVFELLMDIDL--RKKWDKNFEEFEVIEEID 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 317 GHYDVIYCIYDPKYLsrifcrwQSKRDFVFSRQWVRGQDGTYTILQFPAVHKKRPAKSGYRRTEITPSTWEIKSLkkrsd 396
Cdd:cd00177    82 EHTDIIYYKTKPPWP-------VSPRDFVYLRRRRKLDDGTYVIVSKSVDHDSHPKEKGYVRAEIKLSGWIIEPL----- 149
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*
gi 1063734484 397 aETPSCLVTHMLEIHSKRWCKWKRTSYSKFEKTIPYALLLQVAGL 441
Cdd:cd00177   150 -DPGKTKVTYVLQVDPKGSIPKSLVNSAAKKQLASFLKDLRKAKK 193
START smart00234
in StAR and phosphatidylcholine transfer protein; putative lipid-binding domain in StAR and ...
274-415 2.46e-08

in StAR and phosphatidylcholine transfer protein; putative lipid-binding domain in StAR and phosphatidylcholine transfer protein


Pssm-ID: 214575  Cd Length: 205  Bit Score: 54.74  E-value: 2.46e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484  274 VKAVAVVEASADTVFEVLLNiDKHQRYEWDAVTGDSEKIDSYEGHyDVIYCIYDPKYLSRIfcrwqSKRDFVFSRQWVRG 353
Cdd:smart00234  46 FRLVGVVPMVCADLVEELMD-DLEYRPEWDKNVAKAETLEVIDNG-TVIYHYVSKFAAGPV-----SPRDFVFVRYWRED 118
                           90       100       110       120       130       140
                   ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1063734484  354 QDGTYTILQFPAVHKKRPAKSGYRRTEITPSTWEIKSLKKRsdaetpSCLVTHMLEIHSKRW 415
Cdd:smart00234 119 EDGSYAVVDVSVTHPTSPPESGYVRAENLPSGLLIEPLGNG------PSKVTWVSHADLKGW 174
 
Name Accession Description Interval E-value
PLN00188 PLN00188
enhanced disease resistance protein (EDR2); Provisional
60-778 8.93e-105

enhanced disease resistance protein (EDR2); Provisional


Pssm-ID: 215094 [Multi-domain]  Cd Length: 719  Bit Score: 337.55  E-value: 8.93e-105
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484  60 YFGWVYHLGVNKIGHEYCNLRFLFIRGKYVEMYKRDPHENpdIKPIRRGVIGPTMVIEELGRrKVNHGD-VYVIRFYNRL 138
Cdd:PLN00188    6 YEGWMVRYGRRKIGRSYIHMRYFVLESRLLAYYKKKPQDN--QVPIKTLLIDGNCRVEDRGL-KTHHGHmVYVLSVYNKK 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 139 DESRKGEIACATAGEALKWVEAFEEA-KQQAEYALSRG---GSTRTKLSMEANI----------------DLEGHRPRVR 198
Cdd:PLN00188   83 EKYHRITMAAFNIQEALIWKEKIESViDQHQDSQVPNGnkyASFEYKSGMDNGRtasssdhesqfsaqedEEDTHRDLLR 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 199 RYAyglkklirIGQG-PESLLrqSSTLVNDVrgdGFYEGGDNGDAIEAHEWKCVRTINGVRIFEDVANF-----KAGRGV 272
Cdd:PLN00188  163 RTT--------IGNGpPDSVL--DWTKEFDS---ELSNQNSNNQAFSRKHWRLLQCQNGLRIFEELLEVdylprSCSRAM 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 273 lvKAVAVVEASADTVFEVLLNIDKhQRYEWDAVTGDSEKIDSYEGHYDVIYciydpkylSRIFCRWQSK----RDFVFSR 348
Cdd:PLN00188  230 --KAVGVVEATCEEIFELVMSMDG-TRFEWDCSFQYGSLVEEVDGHTAILY--------HRLQLDWFPMfvwpRDLCYVR 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 349 QWVRGQDGTYTILQFPAVHKKRPAKSGYRRTEITPSTWEIKSLKKRSdaETPSCLVTHMLEIHSKRWCKWKRTSYSkfek 428
Cdd:PLN00188  299 YWRRNDDGSYVVLFRSREHENCGPQPGFVRAHLESGGFNISPLKPRN--GRPRTQVQHLMQIDLKGWGVGYIPSFQ---- 372
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 429 tipYALLLQ----VAGLKEYIGAN---------PAFKYETSATVVQSKfqdvpngeyvdeEMEEQFYDATDSSSGEEDEE 495
Cdd:PLN00188  373 ---QHCLLQmlnsVAGLREWFSQTdergappriPVMVNMASASVSSKK------------NQKPQESSPSLDQTNAASRN 437
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 496 ESDDDDENQDNKEIKVKLKNVSWAIASLSLKRpkapgaSNVLDASVDPvsIDPSQFQGSLRKGNGDKDSNCWNSPSGMGF 575
Cdd:PLN00188  438 SVMMDEDSDDDEEFQIPESEQEPETTKNETKD------TAMEEEPQDK--IDLSCFSGNLRRDDRDKARDCWRISDGNNF 509
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 576 MIRGKTYLKDNAKVMGGQPLLTLISVDWFKVDSAVDNIALHPKCLIQSEPGKKLpFILVINLQVPAKPNYCLVLYYAADR 655
Cdd:PLN00188  510 KVRSKNFCYDKSKIPAGKHLMDLVAVDWFKDTKRMDHVARRKGCAAQVAAEKGL-FSFVVNLQVPGSTHYSMVFYFVTKE 588
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 656 PVnKTSSLGKFVDGSDSYRDARFKLIPSIVQGYWMVKRAVGTKACLLGKAVTCKYLRQDNFLEIDVDIGSSAVARSVIGL 735
Cdd:PLN00188  589 LV-PGSLLQRFVDGDDEFRNSRLKLIPSVPKGSWIVRQSVGSTPCLLGKAVDCNYIRGPKYLEIDVDIGSSTVANGVLGL 667
                         730       740       750       760
                  ....*....|....*....|....*....|....*....|...
gi 1063734484 736 VLGYVTSLIVDLAILIEGKEESDLPEYILGTVRLNRIELDSAV 778
Cdd:PLN00188  668 VIGVITTLVVDMAFLVQANTYEELPERLIGAVRVSHVELSSAI 710
EDR2_C pfam07059
Protein ENHANCED DISEASE RESISTANCE 2, C-terminal; This family represents the C-terminus ...
567-771 1.45e-95

Protein ENHANCED DISEASE RESISTANCE 2, C-terminal; This family represents the C-terminus (approximately 250 residues) of protein ENHANCED DISEASE RESISTANCE 2 (EDR2) from plants. EDR2 is a negative regulator of the salicylic acid (SA)-mediated resistance to pathogens, including the biotrophic powdery mildew pathogens Golovinomyces cichoracearum and Blumeria graminis, and the downy mildew pathogen Hyaloperonospora parasitica, probably by limiting the initiation of cell death and the establishment of the hypersensitive response (HR).


Pssm-ID: 462076  Cd Length: 211  Bit Score: 296.05  E-value: 1.45e-95
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 567 WNSPSGMGFMIRGKTYLKDNAKVMGGQPLLTLISVDWFKVDSAVDNIALHPKCLIQSEP-----GKKLPFILVINLQVPA 641
Cdd:pfam07059   1 WSEPDGSTFKVRGPNYLKDKKKVPAGPPLYELVGVDLFKSPKKIDHIASRPELPVALKPsekgaSGKVPFVFVVNLQVPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 642 kPNYCLVLYYAADRPV--NKTSSLGKFVDGSDSYRDARFKLIPSIVQGYWMVKRAVGTKACLLGKAVTCKYLRQDNFLEI 719
Cdd:pfam07059  81 -PGYSLVLYFATEEPLpdDEGSLLDRFVDGDDAFRNERFKLIPRIVNGPWIVKQAVGGKPVLIGKALTCKYHRGHNYFEI 159
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|..
gi 1063734484 720 DVDIGSSAVARSVIGLVLGYVTSLIVDLAILIEGKEESDLPEYILGTVRLNR 771
Cdd:pfam07059 160 DVDIHSSSYARKGLSLVLGYLKSLVVDLGFTIEGQTEEELPERLLGAVRLNK 211
START cd00177
Lipid-binding START domain of mammalian STARD1-STARD15 and related proteins; This family ...
238-441 1.01e-35

Lipid-binding START domain of mammalian STARD1-STARD15 and related proteins; This family includes the steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domains of mammalian STARD1-STARD15, and related domains, such as the START domain of the Arabidopsis homeobox protein GLABRA 2. The mammalian STARDs are grouped into 8 subfamilies. This family belongs to the SRPBCC (START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC) domain superfamily of proteins that bind hydrophobic ligands. SRPBCC domains have a deep hydrophobic ligand-binding pocket. For some members of this family, specific lipids that bind in this pocket are known; these include cholesterol (STARD1/STARD3/ STARD4/STARD5), 25-hydroxycholesterol (STARD5), phosphatidylcholine (STARD2/ STARD7/STARD10), phosphatidylethanolamine (STARD10) and ceramides (STARD11). The START domain is found either alone or in association with other domains. Mammalian STARDs participate in the control of various cellular processes including lipid trafficking between intracellular compartments, lipid metabolism, and modulation of signaling events. Mutation or altered expression of STARDs is linked to diseases such as cancer, genetic disorders, and autoimmune disease. The Arabidopsis homeobox protein GLABRA 2 suppresses root hair formation in hairless epidermal root cells.


Pssm-ID: 176851 [Multi-domain]  Cd Length: 193  Bit Score: 133.62  E-value: 1.01e-35
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 238 DNGDAIEAHE-WKCVRTINGVRIFEDVanFKAGRGVLVKAVAVVEASADTVFEVLLNIDKhqRYEWDAVTGDSEKIDSYE 316
Cdd:cd00177     6 ELLELLEEPEgWKLVKEKDGVKIYTKP--YEDSGLKLLKAEGVIPASPEQVFELLMDIDL--RKKWDKNFEEFEVIEEID 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 317 GHYDVIYCIYDPKYLsrifcrwQSKRDFVFSRQWVRGQDGTYTILQFPAVHKKRPAKSGYRRTEITPSTWEIKSLkkrsd 396
Cdd:cd00177    82 EHTDIIYYKTKPPWP-------VSPRDFVYLRRRRKLDDGTYVIVSKSVDHDSHPKEKGYVRAEIKLSGWIIEPL----- 149
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*
gi 1063734484 397 aETPSCLVTHMLEIHSKRWCKWKRTSYSKFEKTIPYALLLQVAGL 441
Cdd:cd00177   150 -DPGKTKVTYVLQVDPKGSIPKSLVNSAAKKQLASFLKDLRKAKK 193
START smart00234
in StAR and phosphatidylcholine transfer protein; putative lipid-binding domain in StAR and ...
274-415 2.46e-08

in StAR and phosphatidylcholine transfer protein; putative lipid-binding domain in StAR and phosphatidylcholine transfer protein


Pssm-ID: 214575  Cd Length: 205  Bit Score: 54.74  E-value: 2.46e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484  274 VKAVAVVEASADTVFEVLLNiDKHQRYEWDAVTGDSEKIDSYEGHyDVIYCIYDPKYLSRIfcrwqSKRDFVFSRQWVRG 353
Cdd:smart00234  46 FRLVGVVPMVCADLVEELMD-DLEYRPEWDKNVAKAETLEVIDNG-TVIYHYVSKFAAGPV-----SPRDFVFVRYWRED 118
                           90       100       110       120       130       140
                   ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1063734484  354 QDGTYTILQFPAVHKKRPAKSGYRRTEITPSTWEIKSLKKRsdaetpSCLVTHMLEIHSKRW 415
Cdd:smart00234 119 EDGSYAVVDVSVTHPTSPPESGYVRAENLPSGLLIEPLGNG------PSKVTWVSHADLKGW 174
START pfam01852
START domain;
263-415 6.16e-05

START domain;


Pssm-ID: 426476  Cd Length: 205  Bit Score: 44.70  E-value: 6.16e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 263 VANFKAGRGVLVKAVAVVEASADTVFEVLLNiDKHQRYEWDAVTGDS---EKIDSyeghyDVIYCIYDPKYLSRIFCrwq 339
Cdd:pfam01852  34 LQIVEPDHGEASRASGVVPMVAALLVAELLK-DMEYRAQWDKDVRSAetlEVISS-----GGDLQYYVAALVAPSPL--- 104
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1063734484 340 SKRDFVFSRQWVRGQDGTYTILQFPAVHKKRPAKSGYRRTEITPSTWEIKSLKKrsdaetPSCLVTHMLEIHSKRW 415
Cdd:pfam01852 105 SPRDFVFLRYWRRLGGGVYVIVDRSVTHPQFPPSSGYVRAERLPSGYLIQPCGN------GPSKVTWVSHADLKGW 174
START_1 cd08876
Uncharacterized subgroup of the steroidogenic acute regulatory protein (StAR)-related lipid ...
247-378 1.77e-04

Uncharacterized subgroup of the steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domain family; Functionally uncharacterized subgroup of the START domain family. The START domain family belongs to the SRPBCC (START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC) domain superfamily of proteins that bind hydrophobic ligands. SRPBCC domains have a deep hydrophobic ligand-binding pocket. For some mammalian members of the START family (STARDs), it is known which lipids bind in this pocket; these include cholesterol (STARD1, -3, -4, and -5), 25-hydroxycholesterol (STARD5), phosphatidylcholine (STARD2, -7, and -10), phosphatidylethanolamine (STARD10) and ceramides (STARD11). Mammalian STARDs participate in the control of various cellular processes, including lipid trafficking between intracellular compartments, lipid metabolism, and modulation of signaling events. Mutation or altered expression of STARDs is linked to diseases such as cancer, genetic disorders, and autoimmune disease.


Pssm-ID: 176885  Cd Length: 195  Bit Score: 43.41  E-value: 1.77e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 247 EWKCVRTINGVRIFE-DVANFKAgrgVLVKAVAVVEASADTVFEVLLNIDKHQryEWDAVTGDSEKIDSYEGHYDVIYCI 325
Cdd:cd08876    18 DWQLVKDKDGIKVYTrDVEGSPL---KEFKAVAEVDASIEAFLALLRDTESYP--QWMPNCKESRVLKRTDDNERSVYTV 92
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 1063734484 326 YDPKylsrifcrWQ-SKRDFVF-SRQWVRGQDGTYTIlQFPAVHKKRPAKSGYRR 378
Cdd:cd08876    93 IDLP--------WPvKDRDMVLrSTTEQDADDGSVTI-TLEAAPEALPEQKGYVR 138
START_STARD10-like cd08871
Lipid-binding START domain of mammalian STARD10 and related proteins; This subfamily includes ...
273-378 2.28e-04

Lipid-binding START domain of mammalian STARD10 and related proteins; This subfamily includes the steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domains of mammalian STARD10 (also known as CGI-52, PTCP-like, and SDCCAG28). The START domain family belongs to the SRPBCC (START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC) domain superfamily of proteins that bind hydrophobic ligands. SRPBCC domains have a deep hydrophobic ligand-binding pocket. STARD10 binds phophatidylcholine and phosphatidylethanolamine. This protein is widely expressed and is synthesized constitutively in many organs. It may function in the liver in the export of phospholipids into bile. It is concentrated in the sperm flagellum, and may play a role in energy metabolism. In the mammary gland it may participate in the enrichment of lipids in milk, and be a potential marker of differentiation. Its expression is induced in this gland during gestation and lactation. It is overexpressed in mammary tumors from Neu/ErbB2 transgenic mice, in several breast carcinoma cell lines, and in 35% of primary human breast cancers, and may cooperate with c-erbB receptor signaling in breast oncogenesis. It is a potential marker of disease outcome in breast cancer; loss of STARD10 expression in breast cancer strongly predicts an aggressive disease course. The lipid transfer activity of STRAD10 is downregulated by phosphorylation of its Ser284 by CK2 (casein kinase 2).


Pssm-ID: 176880  Cd Length: 222  Bit Score: 43.40  E-value: 2.28e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1063734484 273 LVKAVAV-VEASADTVFEVLLNIDkhQRYEWDAVTGDSEKIDSYEGHYDVIYciYDPKylsrifCRWQSK-RDFVFSRQW 350
Cdd:cd08871    48 MIKVSAIfPDVPAETLYDVLHDPE--YRKTWDSNMIESFDICQLNPNNDIGY--YSAK------CPKPLKnRDFVNLRSW 117
                          90       100
                  ....*....|....*....|....*...
gi 1063734484 351 vRGQDGTYTILQFPAVHKKRPAKSGYRR 378
Cdd:cd08871   118 -LEFGGEYIIFNHSVKHKKYPPRKGFVR 144
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH